Myeov was initially identified as a transforming gene through the application of a NIH/3T3 tumorigenicity assay to DNA from a gastric carcinoma however its role in gastric cancer remains unclear (Janssen et al, 1999). This evidence concerns the gene MYEOV and gastric carcinoma.